companies / endeavorbiomedicines-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-20 json
| total_raised | 295,500,000295.5M | D |
|---|---|---|
| founded | 2018 | |
| hq | San Diego, CA | |
| industry | unknown | |
| stage | series-b+ |
Endeavor BioMedicines is a clinical-stage biotech developing precision medicines for life-threatening diseases, led by taladegib (ENV-101) for idiopathic pulmonary fibrosis. It targets patients with fibrotic lung disease and, via a second program, HER3-positive solid tumors. Its lead IPF candidate is the first to receive PRIME designation and showed improved lung function while reversing disease markers in trials.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2024-04-01 | series-d+ | 132,583,908132.6M | null | D |
| 2022-01-21 | Funding round | 89,119,33189.1M | null | D |
| person | role | src |
|---|---|---|
| Bernard Davitian | director | D |
| Chris Krueger | executive | D |
| Enoch Kariuki | executive | D |
| John Hood | director | D |
| John Hood | executive | D |
| Karan Takhar | director | D |
| Miguel de los Rios | executive | D |
| Monal Mehta |
Nginx, WordPress 7.0, Magnific Popup 1.1.0, Yoast SEO 27.5, Google Tag Manager, Slider Revolution, imagesLoaded 5.0.0, parallax.js, Plesk, OWL Carousel, Bootstrap, PHP
| fact | status | src |
|---|---|---|
| Series D+, $132.6M | sourced | D |
| Funding round, $89.1M | sourced | D |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-09-28latest_round: series-d+, $133.0M, 2024-04-01 → series-d+, $132.6M, 2024-04-01, D 2026-09-25 | latest_round | series-d+, $133.0M, 2024-04-01 → series-d+, $132.6M, 2024-04-01 | D 2026-09-25 |
| 2026-09-25provenance_round: attributed → sourced, D 2026-09-25 | provenance_round | attributed → sourced | D 2026-09-25 |
Records begin 2026-09-24. all_changes
| director |
| D |
| Patrick G. Enright | director | D |
| Raghu Saripalli | executive | D |
| Vishaal Turakhia | executive | D |
| Wing Cheong Lam | director | D |